What the studies show
Single doses of kisspeptin-10 or -54 raise LH within 30 minutes in healthy men and women — one of the most reproducible findings in human neuroendocrinology. Continuous exposure desensitises the response.
Human trials exist and mostly agree, but there are too few of them, they are too small, or one big one is still reading out. Expect the grade to move.
- 1Dhillo WS, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males; and subsequent physiology studies from the same group.J Clin Endocrinol Metab, 2005 onwardThe foundational human dosing studies.
In context
Kisspeptin is the hormone that switches on the reproductive axis: it makes the hypothalamus release GnRH, which drives LH, FSH and the sex hormones. In people it reliably raises LH within minutes, has been used as an egg-maturation trigger in IVF in phase 2 trials, and in two small randomised crossover trials at Imperial College London (32 women, 32 men) increased sexual-brain activation and reduced sexual aversion in people with low sexual desire. All of that is research-scale. It is not an approved medicine anywhere and is prohibited for male athletes.
Kisspeptin is not approved. Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is Kisspeptin proven to help with LH and testosterone release?
What studies are behind the grade?
Is Kisspeptin approved for this?
Other outcomes for Kisspeptin
- CIVF egg maturation trigger2 phase 2 trials
- CSexual desire (women with HSDD)1 crossover RCT (n=32)
- CSexual desire and arousal (men with HSDD)1 crossover RCT (n=32)
- CSafetyadverseSmall studies
Reviewed 3 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →